BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23458233)

  • 41. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
    Baumgartner JM; Ahrendt SA; Pingpank JF; Holtzman MP; Ramalingam L; Jones HL; Zureikat AH; Zeh HJ; Bartlett DL; Choudry HA
    J Surg Oncol; 2013 Mar; 107(4):329-34. PubMed ID: 23386388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes After Surgical Resection Differ by Primary Tumor Location for Metastatic Gastrointestinal Stromal Tumors (GISTs): a Propensity Score Matching Population Study.
    Gaitanidis A; Alevizakos M; Tsaroucha A; Pitiakoudis M
    J Gastrointest Cancer; 2019 Dec; 50(4):750-758. PubMed ID: 30033508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors.
    Patel SR; Benjamin RS
    Surg Oncol; 2000 Aug; 9(2):67-70. PubMed ID: 11094325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.
    Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP
    Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Survival After Multidisciplinary Treatment Including Surgery for Metachronous Metastases of Small Intestinal Gastrointestinal Stromal Tumors after Curative Resection: A Case Report.
    Katayanagi S; Yokoyama T; Makuuchi Y; Osakabe H; Iwamoto H; Sumi T; Hirano H; Katsumata K; Tsuchida A; Hirota S; Kawachi S
    Am J Case Rep; 2019 Dec; 20():1942-1948. PubMed ID: 31875847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
    Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
    World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of a case with disappearance of the primary gastrointestinal stromal tumor and progressive liver metastases under long-term treatment with tyrosine kinase inhibitors.
    Cameron S; Savvoukidis T; Armbrust T; Haller F; Kitz J; Füzesi L; Ramadori G
    Med Oncol; 2010 Jun; 27(2):213-8. PubMed ID: 19294538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
    Wang J; Yin Y; Shen C; Yin X; Cai Z; Pu L; Fu W; Wang Y; Zhang B
    Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and pathological characteristics and their effect on survival in elderly patients with gastrointestinal stromal tumors.
    Molinas Mandel N; Selcukbiricik F; Kanitez M; Yalcin S; Tural D; Erdamar S; Dogusoy G; Demir G
    J BUON; 2016; 21(2):360-5. PubMed ID: 27273945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.
    Serrano C; García-Del-Muro X; Valverde C; Sebio A; Durán J; Manzano A; Pajares I; Hindi N; Landolfi S; Jiménez L; Rubió-Casadevall J; Estival A; Lavernia J; Safont MJ; Pericay C; Díaz-Beveridge R; Martínez-Marín V; Vicente-Baz D; Vivancos A; Hernández-Losa J; Arribas J; Carles J
    Oncologist; 2019 May; 24(5):680-687. PubMed ID: 30126859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
    Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
    Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.
    Bechtold RE; Chen MY; Stanton CA; Savage PD; Levine EA
    Abdom Imaging; 2003; 28(6):808-14. PubMed ID: 14753595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Management of liver metastases of gastrointestinal stromal tumor].
    Hao CY; Qian HG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):221-4. PubMed ID: 22454162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical treatment for gastric GIST with special reference to liver metastases.
    Maehara N; Chijiiwa K; Eto T; Funagayama M; Uchiyama S; Nakashima S; Hidaka H; Hotokezaka M
    Hepatogastroenterology; 2008; 55(82-83):512-6. PubMed ID: 18613398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
    Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor.
    DeMatteo RP; Maki RG; Singer S; Gonen M; Brennan MF; Antonescu CR
    Ann Surg; 2007 Mar; 245(3):347-52. PubMed ID: 17435539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.